Abvc Biopharma (ABVC) Raw Materials (2018 - 2019)
Abvc Biopharma's (ABVC) quarterly Raw Materials came in at $57904.0 in Q4 2019, up 2.14% YoY from $56691.0 in Q4 2018, and up 3.71% on a QoQ basis from $55835.0 in Q3 2019.
Abvc Biopharma (ABVC) Raw Materials (2018 - 2019) Analysis & Trends
Abvc Biopharma (ABVC) has 2 years of Raw Materials data on file, last reported at $57904.0 in Q4 2019.
- Quarterly Raw Materials rose 2.14% year-over-year to $57904.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $57904.0 (up 2.14% YoY) and the FY2019 annual result came in at $57904.0, up 2.14% from the prior year.
- Raw Materials grew to $57904.0 in Q4 2019, from $55835.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $57904.0 in Q4 2019 to a low of $55824.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 57,904.00 |
| Sep 30, 2019 | 55,835.00 |
| Jun 30, 2019 | 55,824.00 |
| Mar 31, 2019 | 56,171.00 |
| Dec 31, 2018 | 56,691.00 |